Main Street Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$123 Hold
1
– – ﹤0.01% 848
2026
Q2
$118 Sell
1
-105
-99% -$11.4K ﹤0.01% 815
2026
Q1
$11K Buy
+106
New +$11.2K ﹤0.01% 527

Other funds holding PJP

Main Street Group's PJP Position: Q3 2026 in Review

Main Street Group held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2026 at 1 share worth $123. The position accounts for ﹤0.01% of the portfolio, ranked #848.

Main Street Group first reported a position in PJP in Q1 2026 and has held it in 3 quarters since. The position peaked at $11K in Q1 2026. 135 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

  • Main Street Group held 1 share of Invesco Pharmaceuticals ETF worth $123 as of Q3 2026.
  • Main Street Group left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Main Street Group's portfolio in Q3 2026, its #848 holding.
  • Main Street Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and has held it in 3 quarters since.
  • Main Street Group's Invesco Pharmaceuticals ETF position peaked at $11K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Main Street Group's 13F filing for Q3 2026, filed 28 Oct 2026.